Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm

Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

17 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03120624	VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer	active not recruiting	Phase 1	34	Mayo ClinicOTHER	1	Jul 21, 2026	clinicaltrials
NCT05001282	A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)	terminated	Phase 1 / Phase 2	79	Elucida OncologyINDUSTRY	1	Aug 7, 2024	clinicaltrials
NCT02020707	Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers	completed	Phase 1	43	Mayo ClinicOTHER	1	Jul 26, 2024	clinicaltrials

Data updated 23 days agoSource updated Jul 21, 2026source: clinicaltrials